Do Wall Street Analysts Like Insulet Stock?

Acton, Massachusetts-based Insulet Corporation (PODD) is a medical device company that develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. With a market cap of $22.8 billion, Insulet’s operations span the United States, Canada, Europe, the Middle East, Australia, and internationally.

Shares of PODD have significantly outpaced the broader market over the past 52 weeks. PODD stock has soared 77.3% over this period, while the broader S&P 500 Index ($SPX) has gained 10.1%. Moreover, shares of PODD are up 23% on a YTD basis, compared to SPX’s marginal dip.